Table 1 Estimated differences between patients with (n = 190) and without (n = 74) follow-up data
Predictor | Summary | Difference between patients with versus without follow-up (95% CI)a | p Value |
|---|---|---|---|
Baseline WMH volume, ml, mean ± SD | 22.0 ± 24.8 | −4.1 (−10.8 to 2.7) | 0.23 |
Age, years, mean ± SD | 65.3 ± 11.3 | 5.7 (−8.8 to −2.6) | 0.0004 |
MAP, mmHg, mean ± SD | 102.8 ± 15.4 | 0.50 (−3.61 to 4.61) | 0.81 |
PP, mmHg, mean ± SD | 63 ± 20.7 | −0.45 (−5.88 to 4.98) | 0.87 |
Hypertension, n (%) | 142 (74.7) | 8.5% (−3.9 to 20.9%) | 0.16 |
Stroke subtype lacunar, n (%) | 87 (45.8) | 3.9% (−9.4 to 17.2%) | 0.57 |
Smoker (current and recent ex-smokers), n (%) | 73 (38.4) | −1.9% (−15.1 to 11.4%) | 0.78 |
Diabetes, n (%) | 21 (11.1) | −1.1% (−9.8 to 7.8%) | 0.80 |
Hyperlipidaemia, n (%) | 116 (61.1) | 0.2% (−12.9 to 13.4%) | 0.97 |
Fazekas score = 0, n (%) | 8 (4.2) | 1.5% (−3.2 to 6.2%) | Overall p value = 0.049 |
Fazekas score = 1, n (%) | 17 (9.0) | −1.9% (−10.0 to 6.3%) | |
Fazekas score = 2, n (%) | 70 (36.8) | 8.5% (−3.9 to 20.8%) | |
Fazekas score = 3, n (%) | 24 (12.6) | 3.2% (−5.0 to 11.3%) | |
Fazekas score = 4, n (%) | 29 (15.3) | 8.5% (−0.8 to 16.2%) | |
Fazekas score = 5, n (%) | 17 (9.0) | −8.6% (−18.2 to 1.0%) | |
Fazekas score = 6, n (%) | 25 (13.2) | −11.2% (−22.1 to 0.3%) |